Stem cell injections for pets – MyFox Atlanta
MyFox Atlanta |
Stem cell injections for pets
MyFox Atlanta Dr. Gaston says the advantage is that human stem cells can differentiate into any organ- where using an animal’s own cells limits the use to a specific area. The human stem cell injection is also less expensive and less time consuming- The stem cells … |
|
What do you want to know about adult stem cell research?
OneNewsNow Dr. David Prentice of the Charlotte Lozier Institute tells OneNewsNow the overall project, StemCellResearchFacts.org, is designed to educate people about the success with research on ethical adult stem cells. “That debate has kind of gone away a little … |
Livemint |
Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug …
PR Newswire (press release) Commenting on the Japan patent, Mr. B N Manohar, CEO of Stempeutics, said, “The new patent strengthens our position in Japan, which has created an accelerated development path for stem cell therapies. The new regenerative medicine law implemented … Cipla JV Gets Process Patent for Stem Cell Drug From JapanNDTV Stempeutics gets process patent from Japan for stem cell-based drugLivemint Stempeutics receives ODD in EU for its novel stem cell drug “Stempeucel”Zee News Financial Express –Pharmaceutical Processing all 18 news articles » |
ABC Online |
Stem cell therapy dilemma
ABC Online In Australia a loophole in the Therapeutic Goods Administration Act allows the use of ‘autologous’, or a person’s own, stem cells. This treatment isn’t proven to be safe or effective and it’s prompted calls for tougher legislation. But as Hamish … Global Stem Cells Group, Stem Cell Training and Anti-aging Medicine Specialist …Virtual-Strategy Magazine (press release) (registration) (blog) |
|
Accellta Grants Rights for its Feeder-free Stem Cell Culture Medium to Thermo …
PR Newswire (press release) Stem Cell Company Accellta announced today that it has granted worldwide non-exclusive rights to Thermo Fisher Scientific for manufacture and distribution of proprietary cell culture medium and ancillary products and methods. Accellta’s patented … |
Livemint |
Cipla JV Gets Process Patent for Stem Cell Drug From Japan
NDTV New Delhi: Drug major Cipla on Monday said its joint venture firm Stempeutics Research has received a process patent from the Japan Patent Office for novel stem cell drug Stempeucel aimed at treatment of critical limb ischemia (CLI). “The new patent … Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’Financial Express Stempeutics gets process patent from Japan for stem cell-based drugLivemint Stempeutics receives Japan process patent for its novel stem cell drug …Hindu Business Line |
|
What do you want to know about adult stem cell research?
OneNewsNow “That debate has kind of gone away a little bit, but most people will remember the debates over embryonic versus adult stem cells, and, of course, the short story is that embryonic — you have to destroy a young human life to get embryonic stem cells … |